Showing results (1541-1550 of 1,694) with videos related to
Sort By:
Pageof 170
Biomedicines|April 30, 2021
Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic TransplantationAlexis Laurent, Philippe Abdel-Sayed, Anthony Grognuz, et al.Antimicrobial Agents and Chemotherapy|July 15, 2020
Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe TrialYi Zheng, Déborah Hirt, Sandrine Delmas, et al.Bioengineering (Basel, Switzerland)|November 27, 2025
Preclinical Mechanistic Evaluation of Hyaluronan/Niacinamide (Vitamin B3) Hydrogels: Toward an Enhanced Viscosupplement System with Ancillary Anti-Arthritic AttributesFarid Hadjab, Stivens Antoine, Béatrice Hamel, et al.European Journal of Radiology|December 3, 2019
Coronary CT angiography derived plaque markers correlated with invasive instantaneous flow reserve for detecting hemodynamically significant coronary stenosesStefan Baumann, Gökce H Özdemir, Christian Tesche, et al.IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|December 24, 2004
AMON: a wearable multiparameter medical monitoring and alert systemUrs Anliker, Jamie A Ward, Paul Lukowicz, et al.Journal of Experimental Botany|March 21, 2014
Salt-induced subcellular kinase relocation and seedling susceptibility caused by overexpression of Medicago SIMKK in ArabidopsisMiroslav Ovečka, Tomáš Takáč, George Komis, et al.Pharmaceutics|December 28, 2021
Combination of Hyaluronan and Lyophilized Progenitor Cell Derivatives: Stabilization of Functional Hydrogel Products for Therapeutic Management of Tendinous Tissue DisordersAlexis Laurent, Alexandre Porcello, Paula Gonzalez Fernandez, et al.Antimicrobial Agents and Chemotherapy|April 6, 2011
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)Déborah Hirt, Didier K Ekouévi, Alain Pruvost, et al.Antimicrobial Agents and Chemotherapy|May 10, 2017
Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years OldClaire Pressiat, Madeleine Amorissani-Folquet, Caroline Yonaba, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2006
Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II studyM Montemurro, T Kiefer, F Schüler, et al.Pageof 170